Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -210,304 | -161,336 | -123,321 | -97,263 | -41,533 |
| Depreciation Amortization | 4,635 | -3,149 | 17 | 2,797 | 1,310 |
| Accounts receivable | 0 | 1,983 | 15 | 7,281 | -2,227 |
| Accounts payable and accrued liabilities | 1,428 | 2,969 | -1,351 | 891 | 922 |
| Other Working Capital | 9,089 | 1,251 | 4,217 | 6,917 | -1,209 |
| Other Operating Activity | 39,649 | 41,921 | 25,792 | 3,934 | 5,466 |
| Operating Cash Flow | $-155,503 | $-116,361 | $-94,631 | $-75,443 | $-37,271 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 144,188 | -126,091 | -148,444 | 75,652 | -209,334 |
| PPE Investments | -3,848 | -921 | -1,760 | -1,953 | -1,532 |
| Investing Cash Flow | $140,340 | $-127,012 | $-150,204 | $73,699 | $-210,866 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,910 | N/A | 9,850 | N/A | N/A |
| Common Stock Issued | 3,207 | 275,252 | 217,561 | 2,984 | 161,193 |
| Other Financing Activity | 0 | -847 | -557 | -457 | 52,019 |
| Financing Cash Flow | $23,117 | $274,405 | $226,854 | $2,527 | $213,212 |
| Beginning Cash Position | 64,716 | 33,684 | 51,665 | 50,882 | 85,807 |
| End Cash Position | 72,670 | 64,716 | 33,684 | 51,665 | 50,882 |
| Net Cash Flow | $7,954 | $31,032 | $-17,981 | $783 | $-34,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -155,503 | -116,361 | -94,631 | -75,443 | -37,271 |
| Capital Expenditure | -3,848 | -921 | -1,760 | -1,953 | -1,532 |
| Free Cash Flow | -159,351 | -117,282 | -96,391 | -77,396 | -38,803 |